Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Neoadjuvant Docetaxel and ZD 1839 (Iressa) Followed by Radical Prostatectomy in Patients With High Risk, Locally Advanced Prostate Cancer

NCT00242918 is registered in ClinicalTrials.gov with Benaroya Research Institute as lead sponsor.

NCT NCT00242918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Neoadjuvant Docetaxel and ZD 1839 (Iressa) Followed by Radical Prostatectomy in Patients With High Risk, Locally Advanced Prostate Cancer
Lead sponsor
Benaroya Research Institute
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2003
Completion date
November 30, 2007
Enrollment
29
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer